Search BioMedTracker
All
Catalysts
Impact Events
Target
Trials
Drug Profiles
Company Profiles
Indication
Login
Coverage Universe
Drugs Covered:
4,199
Catalysts Covered:
5,006
Revenue Models:
415
Companies Covered:
1,023
Companies Evaluated:
25
>>
Advanced Catalyst Search
<<
>>
Advanced Drug Search
<<
>>
Advanced Event Search
<<
Search
Catalysts
Drug Profiles
Impact Events
Company Profiles
Target
Indication
Sample Reports
Special Reports
08/12/10
2010 Post-ADA Report
08/11/10
2010 BioMedTracker Post-ASCO Report
07/09/10
Q3 2010 BMT Outlook Report
06/21/10
2010 Pre-ADA Report
06/06/10
2010 ASCO Weekend Update
05/20/10
2010 Pre-ASCO Report
04/30/10
2010 BioMedTracker ASCO Planner
04/12/10
2010 Pre-EASL Report
More...
Date
Report Title
08/12/10
2010 Post-ADA Report
08/11/10
2010 BioMedTracker Post-ASCO Report
07/09/10
Q3 2010 BMT Outlook Report
06/21/10
2010 Pre-ADA Report
06/06/10
2010 ASCO Weekend Update
05/20/10
2010 Pre-ASCO Report
04/30/10
2010 BioMedTracker ASCO Planner
04/12/10
2010 Pre-EASL Report
04/08/10
Q2 2010 BMT Outlook Report
04/05/10
BioMedTracker FDA Report Update - 2010
03/17/10
Rheumatoid Arthritis Indication Report
02/04/10
2010 BioMedTracker Outlook Report
01/19/10
JP Morgan Conference Review
12/21/09
2009 Post-ASH Report
11/30/09
2009 Pre-ASH Report
11/19/09
Vivus (VVUS) Coverage Initiation
11/13/09
H1N1 Influenza Pandemic Tracker
11/02/09
2009 Post-ACR Report
10/15/09
ACR Conference Catalysts
09/28/09
Q4 2009 BMT Outlook Report
09/21/09
Hepatitis B Indication Report
07/07/09
2009 Post-ADA Report
06/25/09
2009 Post-ASCO Report
05/31/09
2009 ASCO Weekend Update
05/28/09
2009 Pre-ADA Report
05/14/09
2009 Pre-ASCO Report
04/09/09
Diabetes Regulatory Update
03/24/09
Diabetes Approval Timing Update
02/06/09
2009 BioMedTracker Outlook Report
12/18/08
2008 Post-ASH Report
12/02/08
2008 ASH Preview
09/25/08
Cougar (CGRB) Coverage Initiation
08/14/08
2008 Post-ICAD Report
07/24/08
2008 Pre-ICAD Report
07/10/08
Diabetes Update Following 2008 ADA and FDA Advisory Committee Meetings
06/17/08
2008 Post-ASCO Report
05/30/08
2008 Pre-ADA Report
05/15/08
2008 ASCO Abstract Summary
05/12/08
2008 Pre-ASCO Report
05/05/08
Bipolar Indication Report
02/01/08
2008 BioMedTracker Outlook
01/08/08
FDA Approval Study
12/18/07
2007 Post-ASH Report
12/12/07
Kuvan PDUFA Sensitivity Analysis
12/07/07
Multiple Sclerosis (MS) Indication Report
12/04/07
2007 Pre-ASH Report
11/09/07
BioMarin (BMRN) Valuation Update
10/30/07
2007 AASLD Preview
10/01/07
Salix (SLXP) Coverage Initiation
09/21/07
Catalyst Impact Study
09/21/07
Orexigen (OREX) Coverage Initiation
08/28/07
Schizophrenia Indication Report
07/27/07
HGSI Coverage Initiation
07/09/07
2007 Post-ADA Report
06/21/07
2007 Post-ASCO Report
06/15/07
InterMune Coverage Initiation
05/17/07
2007 Pre-ASCO Report
04/27/07
Spectrum Coverage Initiation
04/13/07
Idiopathic Pulmonary Fibrosis (IPF) Indication Report
03/30/07
2007 Post-ACC Report
03/13/07
HIV Indication Report - Update
03/01/07
CDAD Indication Report
02/23/07
Obesity Indication Report - Update
01/31/07
2007 BioMedTracker Outlook
01/19/07
5 and 10 Year Pipeline Updates
12/20/06
2006 Post-ASH Report
12/08/06
2006 Pre-ASH Report
12/01/06
Glioblastoma Multiforme (GBM) Indication Report
10/30/06
Hereditary Angioedema (HAE) Indication Report
10/20/06
Renovis Coverage Initiation
10/04/06
Coley Coverage Initiation
09/22/06
Hypercholesterolemia/ Dyslipidemia Indication Report
08/31/06
NSCLC Indication Report - Update
07/13/06
Type II Diabetes Indication Report - Update
07/12/06
Renal Cell Cancer Indication Report - Update
06/21/06
2006 Post-ASCO Report
06/20/06
Sepracor Coverage Initiation
06/16/06
2006 Post-ADA Report
05/30/06
2006 ASCO Preview
05/12/06
Insomnia Indication Report - Update
05/08/06
Spreading Agents Indication Report
05/04/06
Panacos Coverage Initiation
05/02/06
HIV Indication Report - Update
04/13/06
Arena Coverage Initiation
04/12/06
Resistant Hypertension Indication Report
03/28/06
Systemic Lupus Erythematosus (SLE) Indication Report
03/17/06
Asthma Indication Report
03/09/06
MannKind Coverage Initiation
03/01/06
Pharmion and GPC Biotech AG Coverage Initiation
02/08/06
HPV Vaccine Report
01/31/06
Cardiome Coverage Initiation
01/24/06
Obesity Indication Report
01/11/06
2006 BioMedTracker Outlook
12/22/05
COPD Indication Report
12/15/05
2005 Post-ASH Report
12/01/05
2005 ASH Catalyst Preview
11/08/05
Hepatitis C Indication Report
10/10/05
HIV/AIDS Indication Report
10/07/05
Alkermes Coverage Initiation
08/29/05
Nabi Coverage Initiation
08/25/05
ACS, CABG, and PCI Indication Report
08/15/05
Renal Cell Cancer Indication Report
07/21/05
Parkinson Disease Indication Report
07/20/05
Ligand Coverage Initiation
07/11/05
Celgene Coverage Initiation
06/29/05
2005 ADA Post-Conference Report
05/25/05
2005 Post ASCO Report
05/10/05
2005 ASCO Preview
05/09/05
Cubist Coverage Initiation
05/02/05
Skin and Skin-Structure Infections Indication Report
04/13/05
NPS Coverage Initiation
03/31/05
Incyte Corporation Coverage Initiation
03/28/05
NSCLC Indication Report
02/25/05
Ischemic Stroke Indication Report
02/11/05
Alzheimer's Disease Indication Report
01/27/05
Hypertension Indication Report
01/14/05
Myelodysplastic Syndrome Indication Report
01/13/05
Type II Diabetes Indication Report
01/06/05
2005 BioMedTracker Outlook
12/14/04
Insomnia Indication Report
12/10/04
Post-ASH Coverage 2004
12/07/04
Wet AMD Indication Report
12/02/04
Pre-ASH Coverage 2004
11/16/04
Multiple Sclerosis Indication Report
11/08/04
Osteoporosis Indication Report
Questions?
Email
Customer Support
Privacy Policy
Important Legal Disclosure
Copyright © 2010 Sagient Research Systems, Inc. All rights reserved.